211 related articles for article (PubMed ID: 21666220)
1. Global eradication of measles: an epidemiologic and economic evaluation.
Levin A; Burgess C; Garrison LP; Bauch C; Babigumira J; Simons E; Dabbagh A
J Infect Dis; 2011 Jul; 204 Suppl 1():S98-106. PubMed ID: 21666220
[TBL] [Abstract][Full Text] [Related]
2. Assessing the cost-effectiveness of measles elimination in Uganda: local impact of a global eradication program.
Babigumira JB; Levin A; Burgess C; Garrison LP; Bauch CT; Braka F; Mbabazi WB; Nabyonga JO; Simons E; Dabbagh A
J Infect Dis; 2011 Jul; 204 Suppl 1():S116-23. PubMed ID: 21666152
[TBL] [Abstract][Full Text] [Related]
3. Using cost-effectiveness analysis to support research and development portfolio prioritization for product innovations in measles vaccination.
Garrison LP; Bauch CT; Bresnahan BW; Hazlet TK; Kadiyala S; Veenstra DL
J Infect Dis; 2011 Jul; 204 Suppl 1():S124-32. PubMed ID: 21666153
[TBL] [Abstract][Full Text] [Related]
4. How can measles eradication strengthen health care systems?
Griffiths UK; Mounier-Jack S; Oliveira-Cruz V; Balabanova D; Hanvoravongchai P; Ongolo P
J Infect Dis; 2011 Jul; 204 Suppl 1():S78-81. PubMed ID: 21666217
[TBL] [Abstract][Full Text] [Related]
5. Determining measles-containing vaccine demand and supply: an imperative to support measles mortality reduction efforts.
Costa A; Henao-Restrepo AM; Marie Hall S; Jarrett S; Hoekstra EJ
J Infect Dis; 2003 May; 187 Suppl 1():S22-8. PubMed ID: 12721888
[TBL] [Abstract][Full Text] [Related]
6. Strategic planning for measles control: using data to inform optimal vaccination strategies.
Simons E; Mort M; Dabbagh A; Strebel P; Wolfson L
J Infect Dis; 2011 Jul; 204 Suppl 1():S28-34. PubMed ID: 21666174
[TBL] [Abstract][Full Text] [Related]
7. Global measles control and regional elimination, 1998-1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1999 Dec; 48(49):1124-30. PubMed ID: 10634347
[TBL] [Abstract][Full Text] [Related]
8. Future savings from measles eradication in industrialized countries.
Carabin H; Edmunds WJ
J Infect Dis; 2003 May; 187 Suppl 1():S29-35. PubMed ID: 12721889
[TBL] [Abstract][Full Text] [Related]
9. Progress toward global measles control and regional elimination, 1990-1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1998 Dec; 47(48):1049-54. PubMed ID: 9869078
[TBL] [Abstract][Full Text] [Related]
10. Comparing measles with previous eradication programs: enabling and constraining factors.
Keegan R; Dabbagh A; Strebel PM; Cochi SL
J Infect Dis; 2011 Jul; 204 Suppl 1():S54-61. PubMed ID: 21666211
[TBL] [Abstract][Full Text] [Related]
11. Economic analysis of the 1996-1997 mass measles immunization campaigns in South Africa.
Uzicanin A; Zhou F; Eggers R; Webb E; Strebel P
Vaccine; 2004 Sep; 22(25-26):3419-26. PubMed ID: 15308367
[TBL] [Abstract][Full Text] [Related]
12. Update: global measles control and mortality reduction--worldwide, 1991-2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 May; 52(20):471-5. PubMed ID: 12807081
[TBL] [Abstract][Full Text] [Related]
13. [An economic evaluation of measles vaccination in District 3 of the city of Bucharest].
Ion-Nedelcu N; Mihăileanu C; Dobrescu A
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1989; 34(2):163-8. PubMed ID: 2506626
[TBL] [Abstract][Full Text] [Related]
14. The Americas: paving the road toward global measles eradication.
Castillo-Solorzano C C; Matus CR; Flannery B; Marsigli C; Tambini G; Andrus JK
J Infect Dis; 2011 Jul; 204 Suppl 1():S270-8. PubMed ID: 21666172
[TBL] [Abstract][Full Text] [Related]
15. Is there enough vaccine to eradicate measles? An integrated analysis of measles-containing vaccine supply and demand.
Smith G; Michelson J; Singh R; Dabbagh A; Hoekstra E; van den Ent M; Mallya A
J Infect Dis; 2011 Jul; 204 Suppl 1():S62-70. PubMed ID: 21666215
[TBL] [Abstract][Full Text] [Related]
16. Progress in reducing measles mortality--worldwide, 1999-2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Mar; 54(8):200-3. PubMed ID: 15744229
[TBL] [Abstract][Full Text] [Related]
17. The Measles Initiative: moving toward measles eradication.
Christie AS; Gay A
J Infect Dis; 2011 Jul; 204 Suppl 1():S14-7. PubMed ID: 21666155
[TBL] [Abstract][Full Text] [Related]
18. Progress in reducing global measles deaths, 1999-2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(9):247-9. PubMed ID: 16528234
[TBL] [Abstract][Full Text] [Related]
19. Measles control in developing and developed countries: the case for a two-dose policy.
Tulchinsky TH; Ginsberg GM; Abed Y; Angeles MT; Akukwe C; Bonn J
Bull World Health Organ; 1993; 71(1):93-103. PubMed ID: 8440043
[TBL] [Abstract][Full Text] [Related]
20. Progress in global measles control and mortality reduction, 2000-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Nov; 56(47):1237-41. PubMed ID: 18046301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
